KRYS Krystal Biotech Inc
Company Analysis
Latest News
Krystal Biotech Reports Positive KB-301 Phase 2 Results for Netherton Syndrome
Krystal Biotech, Inc. announced positive topline results from its Phase 2 trial of KB-301 for Netherton syndrome, a rare and severe genetic skin disorder. The...
🟢 Krystal Biotech is trading 7% up in pre-market — no clear company-specific catalyst identified
Krystal Biotech is trading at $333.34, up 7.01%, in pre-market on October 26, 2026; no clear new company-specific catalyst was identified. - The latest company...
Krystal Biotech KB113 Shows 80% Lesion Regression in Gorlin Syndrome Study
Krystal Biotech, Inc. presented positive pilot study data for its KB113 dermatology program at the 14th Pediatric Dermatology Research Alliance (PeDRA) Annual...
🔴 Krystal Biotech is trading 4.1% down amid biotech and broader-market weakness
Krystal Biotech is trading 4.1% lower at $316.55 as biotech and broader-market weakness is the likeliest explanation, though no direct cause for the stock’s...
Krystal Biotech Reports Positive KB113 Data in Gorlin Syndrome Pilot Study
Krystal Biotech announced positive clinical data from its pilot study of KB113, an immunotherapy for treating basal cell carcinomas (BCCs) in patients with...
🔴 Krystal Biotech is trading 5.19% down in after-hours trading amid rate concerns after hotter-than-forecast CPI
Krystal Biotech is trading at $313.54, down 5.19% in after-hours trading amid broader market weakness; no clear company-specific announcement was identified...
🟢 Krystal Biotech is trading 4.5% up in after-hours trading; no company-specific catalyst identified
Krystal Biotech is trading 4.52% up in after-hours at $335.69, with no new company-specific announcement identified to explain the rise. - The regular-session...
🟢 Krystal Biotech is trading 7.2% up in pre-market; catalyst remains unclear
Krystal Biotech is trading 7.16% up at $347.80 in pre-market on October 8, 2026; the reason for the gain remains unclear. - The prior close was $324.57. -...
🔴 Krystal Biotech is trading 4.15% down today as biotech ETF falls 2.50%
Krystal Biotech is trading at $320.96, down -4.15%, with biotech-sector weakness the clearest available explanation. - No October 6 company-specific...
🟢 Krystal Biotech is trading 4.1% up with no confirmed company-specific explanation
Krystal Biotech is trading 4.1% higher at $335.50 on October 5, 2026; no company-specific explanation is confirmed. - Its investor-relations news page lists no...
Goldman Sachs Rates Krystal Biotech Buy, Citing 95% Profit Margins
Goldman Sachs initiated coverage on Krystal Biotech Inc. (NASDAQ:KRYS) with a Buy rating. The investment bank established a price target of $441.00 for the...
🟢 Krystal Biotech is trading 7% up in after-hours trading
Krystal Biotech is trading 7.02% higher at $365.75 after closing at $341.75 on September 23, 2026; no company-specific catalyst for the after-hours gain was...
🟢 Krystal Biotech is trading 4.24% up today; catalyst remains unclear
Krystal Biotech is trading 4.24% up at $348.01, with no clear company-specific catalyst identified. - No announcement, earnings release, regulatory decision,...
🟢 Krystal Biotech is trading 4.57% up in pre-market amid broader risk-on sentiment
Krystal Biotech is trading 4.57% up at $354.22, with the move appearing aligned with broader risk-on sentiment. - It closed at $338.75 on September 17,...
🟢 Krystal Biotech is trading 4.3% up in after-hours trading
Krystal Biotech is trading 4.3% up at $360.23 after its September 10, 2026 Cantor Global Healthcare Conference presentation. - Management discussed continued...
🟢 Krystal Biotech is trading 5.89% up in pre-market
Krystal Biotech is trading 5.89% up at $368.60, with the catalyst uncertain. - No fresh earnings release, FDA decision, acquisition, or other definitive...
Krystal Biotech Executives Sell $18M in Stock, Shares Near 52-Week High
Krystal Biotech CEO Krish S. Krishnan and R&D President Suma Krishnan sold nearly $18 million in company stock. These transactions occurred on September 4,...
🔴 Krystal Biotech is trading 4.09% down with no clear company-specific catalyst
Krystal Biotech is trading 4.09% down now at $356.29 on September 4, 2026, with no fresh company-specific announcement, earnings release, regulatory action, or...
🟢 Krystal Biotech is trading 4.05% up today on broad biotechnology-sector strength
Krystal Biotech is trading 4.05% up now at $355.56 as biotechnology shares strengthen broadly. - The XBI sector ETF is up 2.06%, providing a meaningful...
🔴 Krystal Biotech is trading 22.21% down in after-hours trading with no clear company-specific catalyst identified
Krystal Biotech is trading 22.21% down at $269.59 after no clear company-specific announcement was identified for August 21, 2026. - Latest reported earnings,...